The stock of Chimerix Inc. (NASDAQ:CMRX) decreased by -$0.01 on Wednesday to $0.96, down -1.44 percent. The last five days have seen an average of 773,706 shares of common stock traded. 6 times new highs were reached in the current year, with a fall of -$0.8999. The average number of shares traded over the last 20 days was 789,502, while the average volume over the last 50 days totaled 1,061,541.
CMRX stock dropped -18.29% since last month. On 08/16/23, the company’s shares reached a one-month low of $0.9500. The stock touched a high of $2.74 on 01/13/23, after rallying from a low of $0.96 in 52 weeks. The price of CMRX stock has declined by -48.60% or -$0.8999 this year, reaching a new high 6 times. Still, the stock price is down -65.11% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CMRX stock investors should be aware that Chimerix Inc. (CMRX) stock had its last reported insider trading activity 90 days ago on May 18. On May 18, Chief Business Officer and CFO Andriole Michael T. acquired 51,700 shares at $1.14 each. This transaction resulted in the insider spending $59,150. On May 12, Sherman Michael A. added 87,000 shares at a price of US$1.12. After the transaction, the insider now owns 87,000 shares. Director DEMSKI MARTHA J had earlier bought 18,000 shares on May 10 for $1.11 a share. The transaction was completed for $19,980.
Valuation Metrics
Chimerix Inc. (CMRX) has a trailing price-to-earnings (P/E) ratio of 0.46. Beta for the stock is 1.14. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 2.60, the price-to-book (PB) ratio of 0.38.
Financial Health
For the three months ended June 29, Chimerix Inc.’s current ratio was 13.80. As far as profitability goes, gross margin for the trailing twelve months is 99.00% percent. Based on annual data, it had gross profit of $33.38 million and revenue of $33.82 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. CMRX’s return on assets (ROA) during the last 12 months has been 67.30%. There was a -23.50% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 72.50%.
Earnings Surprise
According to Chimerix Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $30000.0, while revenues fell by -1366.67% to $0.28 million. It was predicted that Chimerix Inc.’s quarterly earnings would be -$0.21, but it ended up being -$0.24, beating the consensus by 12.50%. EBITDA was -$23.16 million for the quarter. At the end of Chimerix Inc.’s most recent quarter ended June 29, its liabilities totaled 16.97 million, while its total debt was $2.11 million. Equity owned by shareholders amounts to $88.58 million.
Technical Picture
Here’s a quick look at Chimerix Inc.’s (CMRX) price momentum from a technical perspective. As of 15 August, the RSI 9-day stood at 20.41%, suggesting the stock is oversold, with a 29.44% historical volatility rate.
The stochastic %K and %D were 8.59% and 8.49% respectively, while the average true range (ATR) was 0.0528. Based on the 14-day stochastic reading of 3.88%, the RSI (14) reading is 25.56%. On the 9-day MACD Oscillator, the stock is at -0.0414, and the 14-day reading is at -0.0974.
Analyst Ratings
In its analyst report released on May 23, 2023, Robert W. Baird began covering Chimerix Inc. (NASDAQ: CMRX). The stock was rated as an Outperform by the brokerage firm. Analysts have assigned Chimerix Inc. (CMRX) an Buy rating. CMRX is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 2 rates it overweight and 5 others recommend it as a buy.
What is CMRX’s price target for the next 12 months?
The current consensus forecast for the stock is between $5.00 and $11.00, with a median target price of $7.00. In analyzing these forecasts, the average price target given by analysts for Chimerix Inc. (CMRX) is $7.00.
